Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
- PMID: 31857933
- PMCID: PMC6881110
- DOI: 10.9740/mhc.2019.11.373
Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
Abstract
Current clinical practice guidelines for the treatment of posttraumatic stress disorder offer varying recommendations regarding the use of pharmacotherapy. Many direct head-to-head comparisons of pharmacotherapy are lacking, and recommendations are based on meta-analyses and small trials. While selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are considered first-line pharmacotherapy, clear distinctions do not exist when considering other classes of psychotropic medications. Ultimately, when selecting an appropriate medication for a patient diagnosed with posttraumatic stress disorder, the clinician needs to consider the current symptomatology being experienced, comorbid conditions, and evidence for efficacy of specific treatments prior to initiating medications.
Keywords: antidepressants; antipsychotics; anxiety; benzodiazepines; mood stabilizers; nightmares; posttraumatic stress disorder (PTSD); prazosin.
© 2019 CPNP. The Mental Health Clinician is a publication of the College of Psychiatric and Neurologic Pharmacists.
Conflict of interest statement
Disclosures: I have nothing personal to disclose. Psychopharmacology Pearls are review articles intended to highlight both the evidence base available and/or controversial areas of clinical care for psychiatric and neurologic conditions as well as strategies of clinical decision-making used by expert clinicians. As pearls, articles reflect the views and practice of each author as substantiated with evidence-based facts as well as opinion and experience. Articles are edited by members of the Psychopharmacology Pearls Editorial Board as well as peer reviewed by MHC reviewers. This article was developed as part of the 2019 Psychopharmacology Pearls product for BCPP recertification credit. The course information and testing center is at https://cpnp.org/379404.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association;; 2013.
-
- Ursano RJ, Kessler RC, Stein MB, Naifeh JA, Aliaga PA, Fullerton CS, et al. Risk factors, methods, and timing of suicide attempts among US army soldiers. JAMA Psychiatry. 2016;73(7):741–9. DOI: 10.1001/jamapsychiatry.2016.0600 PubMed PMID: 27224848 PubMed Central PMCID: PMC4937827. - DOI - PMC - PubMed
-
- Smith SM, Goldstein RB, Grant BF. The association between post-traumatic stress disorder and lifetime DSM-5 psychiatric disorders among veterans: data from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) J Psychiatr Res. 2016;82:16–22. DOI: 10.1016/j.jpsychires.2016.06.022 PubMed PMID: 27455424 PubMed Central PMCID: PMC5026976. - DOI - PMC - PubMed
-
- Pietrzak RH, Goldstein RB, Southwick SM, Grant BF. Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord. 2011;25(3):456–65. DOI: 10.1016/j.janxdis.2010.11.010 PubMed PMID: 21168991 PubMed Central PMCID: PMC3051041. - DOI - PMC - PubMed
-
- Goldstein RB, Smith SM, Chou SP, Saha TD, Jung J, Zhang H, et al. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016;51(8):1137–48. DOI: 10.1007/s00127-016-1208-5 PubMed PMID: 27106853 PubMed Central PMCID: PMC4980174. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources